Heparin infusions in aneurysmal subarachnoid hemorrhages: clinical considerations for use beyond anticoagulation.

Zsanett KormanyosJustin P ReinertPaul Brady

Published in: Expert review of clinical pharmacology (2022)

Many options beyond heparin infusions exist in the armamentarium for clinicians when managing aSAH patients. Additional research is required to elucidate therapeutic drug monitoring targets and dosing protocols.

Keyphrases

venous thromboembolism
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
growth factor
prognostic factors
atrial fibrillation
palliative care
patient reported outcomes